Publications by authors named "Kimberly R Jordan"

26Publications

Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.

Breast Cancer Res 2020 Nov 23;22(1):128. Epub 2020 Nov 23.

Young Women's Breast Cancer Translational Program, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-020-01363-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681773PMC
November 2020

Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Cell Rep 2019 11;29(7):1893-1908.e4

Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80302, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.10.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871766PMC
November 2019

Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system.

Drug Des Devel Ther 2018 5;12:3343-3356. Epub 2018 Oct 5.

Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA,

View Article

Download full-text PDF

Source
https://www.dovepress.com/characterization-of-clinical-grade
Publisher Site
http://dx.doi.org/10.2147/DDDT.S175113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181073PMC
February 2019

Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.

Int Immunopharmacol 2018 Oct 16;63:282-291. Epub 2018 Aug 16.

University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA; Division of Surgical Oncology, Department of Surgery, USA; University of Colorado Cancer Center, Aurora, CO, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15675769183038
Publisher Site
http://dx.doi.org/10.1016/j.intimp.2018.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134177PMC
October 2018

The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients.

J Leukoc Biol 2017 08 8;102(2):381-391. Epub 2017 Feb 8.

Department of Surgery, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.5VMR1016-449RDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608076PMC
August 2017

Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.

Cancer Immunol Immunother 2017 Apr 20;66(4):503-513. Epub 2017 Jan 20.

Department of Surgery, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Academic Office One, 12631 E. 17th Ave, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1953-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580403PMC
April 2017

Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.

Cancer Immunol Immunother 2013 Nov 27;62(11):1711-22. Epub 2013 Sep 27.

Department of Surgery, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Academic Office One, Mailstop C313, 12631 E. 17th Ave, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-013-1475-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176615PMC
November 2013

Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.

Cancer Res 2013 Jan 16;73(1):74-85. Epub 2012 Nov 16.

Integrated Department of Immunology, University of Colorado School of Medicine, Denver, CO 80206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-1005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537842PMC
January 2013

Influence of human immune cells on cancer: studies at the University of Colorado.

Immunol Res 2013 Mar;55(1-3):22-33

National Jewish Health, Integrated Department of Immunology, University of Colorado School of Medicine, Denver, CO 80206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-012-8346-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984131PMC
March 2013

TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.

Cancer Immunol Immunother 2012 Oct 21;61(10):1627-38. Epub 2012 Feb 21.

Integrated Department of Immunology, School of Medicine, University of Colorado Denver, 1400 Jackson Street, Room K511, Denver, CO 80206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1217-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410973PMC
October 2012

DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.

J Surg Res 2012 Jul 24;176(1):301-8. Epub 2011 Aug 24.

Department of Surgery, University of Colorado Denver, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2011.07.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674430PMC
July 2012

The Goldilocks model for TCR-too much attraction might not be best for vaccine design.

PLoS Biol 2010 Sep 14;8(9). Epub 2010 Sep 14.

University of Colorado Denver School of Medicine, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
https://dx.plos.org/10.1371/journal.pbio.1000482
Publisher Site
http://dx.doi.org/10.1371/journal.pbio.1000482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939021PMC
September 2010

Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.

Proc Natl Acad Sci U S A 2010 Mar 26;107(10):4652-7. Epub 2010 Jan 26.

Integrated Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, CO 80206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0914879107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842066PMC
March 2010

Age-dependent tolerance to an endogenous tumor-associated antigen.

Vaccine 2008 Mar 20;26(15):1863-1873. Epub 2008 Feb 20.

Integrated Department of Immunology, University of Colorado, Denver.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2008.01.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2295286PMC
March 2008

Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.

J Clin Invest 2006 Sep 24;116(9):2543-51. Epub 2006 Aug 24.

Integrated Department of Immunology, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI26936DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1551931PMC
September 2006

Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands.

Immunol Rev 2006 Apr;210:156-70

Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0105-2896.2006.00365.xDOI Listing
April 2006

Peripheral blood-derived bovine dendritic cells promote IgG1-restricted B cell responses in vitro.

J Leukoc Biol 2003 Jan;73(1):100-6

Department of Veterinary Pathobiology, Program for Prevention of Animal Infectious Diseases, University of Missouri, Columbia, MO 65211, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0302128DOI Listing
January 2003